JPH058049B2 - - Google Patents

Info

Publication number
JPH058049B2
JPH058049B2 JP59272783A JP27278384A JPH058049B2 JP H058049 B2 JPH058049 B2 JP H058049B2 JP 59272783 A JP59272783 A JP 59272783A JP 27278384 A JP27278384 A JP 27278384A JP H058049 B2 JPH058049 B2 JP H058049B2
Authority
JP
Japan
Prior art keywords
core
acid
capsule body
fluid
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP59272783A
Other languages
Japanese (ja)
Other versions
JPS61153135A (en
Inventor
Toshiaki Shiotani
Yasuhiko Shiiki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Snow Brand Milk Products Co Ltd
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Priority to JP59272783A priority Critical patent/JPS61153135A/en
Publication of JPS61153135A publication Critical patent/JPS61153135A/en
Publication of JPH058049B2 publication Critical patent/JPH058049B2/ja
Granted legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02Making microcapsules or microballoons
    • B01J13/06Making microcapsules or microballoons by phase separation
    • B01J13/08Simple coacervation, i.e. addition of highly hydrophilic material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicinal Preparation (AREA)

Description

【発明の詳細な説明】 産業上の利用分野 本発明はキトサンのような可溶性キチン誘導体
を皮膜形成材として用いたカプセル体およびその
製造法に関する。
DETAILED DESCRIPTION OF THE INVENTION Field of Industrial Application The present invention relates to a capsule body using a soluble chitin derivative such as chitosan as a film forming material and a method for producing the same.

従来の技術 従来、カプセル体の製造法として、カプセル体
の芯部を構成する流動体(芯液)にカルシウム塩
のような多価金属塩を添加した混合物を、アルギ
ン酸塩又は低メトキシルペクチンもしくはそれら
の混合物の溶液と接触させることによりゲル皮膜
を形成させる方法(特公昭48−16183号)、カルボ
キシルメチルキチンもしくはカルボキシルメチル
キチン塩の脱N−アセチル化物を含む水溶液を、
無水酢酸と酢酸の混合液のような有機酸の無水物
水溶液中に滴下、攪拌、分散させることによりカ
プセル体を製造する方法(特開昭55−90503号)
等が知られている。しかし、これらの公知方法で
はカプセル体の芯部を構成する液(芯液)のイオ
ン強度が高く、また、カプセルの形成工程で該液
の水素イオン濃度の急激な変化がみられるため、
生物学的に温和な条件下でのカプセル化が困難で
あり、したがつて、生物学的に不安定な物質を内
包させるためのカプセル体の製造法としては適当
でないといえる。
Conventional technology Conventionally, as a method for manufacturing capsule bodies, a mixture of a polyvalent metal salt such as a calcium salt added to a fluid (core liquid) constituting the core of the capsule body is mixed with alginate, low methoxyl pectin, or the like. A method of forming a gel film by contacting with a solution of a mixture of (Japanese Patent Publication No. 48-16183), an aqueous solution containing a de-N-acetylated product of carboxylmethyl chitin or a carboxylmethyl chitin salt,
A method for manufacturing capsule bodies by dropping, stirring, and dispersing an organic acid in an aqueous anhydride solution such as a mixture of acetic anhydride and acetic acid (Japanese Patent Application Laid-open No. 55-90503)
etc. are known. However, in these known methods, the ionic strength of the liquid (core liquid) constituting the core of the capsule body is high, and the hydrogen ion concentration of the liquid changes rapidly during the capsule formation process.
It is difficult to encapsulate under biologically mild conditions, and therefore it is not suitable as a method for manufacturing capsule bodies for encapsulating biologically unstable substances.

発明が解決しようとする問題点 本発明者は、カプセル体の製造に適したゲル皮
膜の形成について研究している過程で、キチン誘
導体の一種であるキトサンの溶液とポリリン酸、
メタリン酸、ピロリン酸またはそれらの塩の溶液
を接触させると、生物学的に温和な条件下で優れ
たゲル皮膜を形成することの知見を得て、本発明
をなすに至つた。
Problems to be Solved by the Invention In the process of researching the formation of a gel film suitable for manufacturing capsule bodies, the present inventor discovered that a solution of chitosan, a type of chitin derivative, and polyphosphoric acid,
The present invention was accomplished based on the finding that an excellent gel film is formed under biologically mild conditions when a solution of metaphosphoric acid, pyrophosphoric acid, or a salt thereof is brought into contact with the material.

すなわち、本発明の目的は、生物学的に温和な
条件下で形成し得るゲル体およびその製造法を提
供することにある。本発明のその他の目的は以下
の説明から明らかになるであろう。
That is, an object of the present invention is to provide a gel body that can be formed under biologically mild conditions and a method for producing the gel body. Other objects of the invention will become apparent from the description below.

以下本発明を詳しく説明する。 The present invention will be explained in detail below.

発明の構成 本発明に係るカプセル体の特徴は、ポリリン
酸、メタリン酸、ピロリン酸またはそれらの塩の
単独もしくはそれらの混合物を基材とする流動体
と、可溶性キチン誘導体の溶液との接触により形
成されたゲル皮膜で、上記流動体を芯部として内
包させたことにある。
Structure of the Invention The capsule body according to the present invention is characterized by being formed by contacting a fluid based on polyphosphoric acid, metaphosphoric acid, pyrophosphoric acid or a salt thereof or a mixture thereof with a solution of a soluble chitin derivative. The reason is that the above-mentioned fluid is encapsulated in the gel film as a core.

また、本発明に係る製造法の特徴は、ポリリン
酸、メタリン酸、ピロリン酸またはそれらの塩の
単独もしくはそれらの混合物を含む溶液から成る
カプセル体の芯部を構成する流動体を、可溶性キ
チン誘導体の溶液に滴下して生物学的に温和な条
件下で接触させて上記流動体を芯部として内包せ
しめてなるゲル皮膜を形成させることにある。
In addition, a feature of the production method according to the present invention is that the fluid constituting the core of the capsule body, which is a solution containing polyphosphoric acid, metaphosphoric acid, pyrophosphoric acid, or a salt thereof, alone or in a mixture thereof, is replaced with a soluble chitin derivative. The objective is to form a gel film containing the above-mentioned fluid as a core by dropping the fluid into a solution and contacting it under biologically mild conditions.

問題点を解決するための手段 本発明においてカプセル体のゲル皮膜を形成す
るに用いるポリリン酸、メタリン酸、ピロリン酸
またはそれらの塩は水溶液中でポリアニオン重合
体となる化合物またはそれらの塩であつて、メタ
リン酸ナトリウム、トリポリリン酸ナトリウム、
ピロリン酸ナトリウム等を例示し得る。これらの
リン酸化合物は単独または混合物として用い得
る。
Means for Solving the Problems In the present invention, polyphosphoric acid, metaphosphoric acid, pyrophosphoric acid, or a salt thereof used to form the gel film of the capsule body is a compound or a salt thereof that becomes a polyanionic polymer in an aqueous solution. , sodium metaphosphate, sodium tripolyphosphate,
Examples include sodium pyrophosphate. These phosphoric acid compounds can be used alone or as a mixture.

一方、同じゲル皮膜の形成に用いる可溶性キチ
ン誘導体は、本来不活性な物質であるキチンに化
学的処理を施してその反応活性を高めたものであ
つて、キチンを脱アセチル化処理して得られるキ
トサンが代表的なものとして例示し得る。
On the other hand, the soluble chitin derivatives used to form the same gel film are obtained by chemically treating chitin, which is originally an inert substance, to increase its reaction activity, and are obtained by deacetylating chitin. Chitosan can be exemplified as a typical example.

因に、キチンはカニ、オキアミ、昆虫等の甲
皮、微生物の細胞壁、きのこ類等に含まれるN−
アセチル−D−グルコサミンがβ(1→4)結合
した直鎖ホモ多糖体であつて、天然に豊富に生産
されるものであるが、その不活性の故にそのまま
では利用できない未利用天然資源といえる。
Incidentally, chitin is N- contained in the carapace of crabs, krill, insects, etc., the cell walls of microorganisms, mushrooms, etc.
It is a linear homopolysaccharide with β (1→4) bonds of acetyl-D-glucosamine, and is produced in abundance in nature, but due to its inactivity it can be said to be an unused natural resource that cannot be used as is. .

しかし、キチンを脱アセチル化処理してえられ
るキトサンのようなキチン誘導体は稀酸に可溶と
なり、反応活性を有するようになる。すなわち、
キトサン下記一般式()で表わされる構造単位
を有し、 式中のアミノ基により正に帯電し、ポリカチオ
ン重合体としてキトサン分子を有していて反応活
性を示す。
However, chitin derivatives such as chitosan obtained by deacetylating chitin become soluble in dilute acids and have reactive activity. That is,
Chitosan has a structural unit represented by the following general formula (), It is positively charged due to the amino group in the formula, has chitosan molecules as a polycationic polymer, and exhibits reactive activity.

したがつて、上述したような可溶性キチン誘導
体のキトサン溶液に、上記リン酸化合物またはそ
の塩もしくはそれらの混合物の水溶液を接触させ
ると、上記リン酸化合物とキトサンとの間に荷電
による架橋反応を起してゲル状物質を生成する。
Therefore, when a chitosan solution of the soluble chitin derivative as described above is brought into contact with an aqueous solution of the phosphoric acid compound, its salt, or a mixture thereof, a crosslinking reaction due to charge occurs between the phosphoric acid compound and chitosan. to produce a gel-like substance.

本発明において上記両溶液の接触を行なうに
は、上記リン酸化合物またはその塩を含む水溶液
をデポジツターなどによりキトサン溶液中に攪拌
下に滴下させるとよく、その際上記架橋反応が起
る。この架橋反応により一旦ゲル皮膜が形成され
ると、該皮膜に内包されて芯部を構成する溶液の
ゲル化は全くみられなくなるので所望のカプセル
体が得られるようになる。このような現象は、ゲ
ル皮膜が形成されると、該皮膜に内包された溶液
(すなわち、芯液)中のポリアニオン重合体およ
びキトサン分子がもはや上記皮膜を透過できなく
なつて、反応が芯液中で進行しなくなることに因
るものと考えられる。
In order to bring the two solutions into contact in the present invention, the aqueous solution containing the phosphoric acid compound or its salt may be dropped into the chitosan solution with stirring using a depositor or the like, and at this time the crosslinking reaction occurs. Once a gel film is formed by this crosslinking reaction, the solution encapsulated in the film and constituting the core will not gel at all, making it possible to obtain the desired capsule. This phenomenon occurs because when a gel film is formed, the polyanionic polymer and chitosan molecules in the solution (i.e., core liquid) contained in the gel film can no longer permeate through the film, and the reaction occurs in the core liquid. This is thought to be due to the fact that it stops progressing inside.

本発明では、カプセル体の芯部を構成する流動
体として用いる溶液の調製に当つては上記リン酸
化合物またはその塩もしくはそれらの混合物を
0.2重量%以上を含む水溶液とすることが適当で
あり、特に上記リン酸化合物としてメタリン酸ナ
トリウムを用いるのがゲル皮膜形成上好ましい。
In the present invention, the above-mentioned phosphoric acid compound, its salt, or a mixture thereof is used in preparing the solution used as the fluid constituting the core of the capsule body.
It is appropriate to use an aqueous solution containing 0.2% by weight or more, and it is particularly preferable to use sodium metaphosphate as the phosphoric acid compound from the viewpoint of forming a gel film.

また、上記水溶液を接触させるキトサン溶液
は、酢酸のような弱酸に0.5〜1.0重量%の濃度に
溶解したものが適当である。
The chitosan solution with which the above aqueous solution is brought into contact is suitably one dissolved in a weak acid such as acetic acid to a concentration of 0.5 to 1.0% by weight.

上述したとおり、本発明では、カプセル体のゲ
ル皮膜を有機溶剤などを使用することなく、極め
て温和な条件、すなわち、生物学的に温和な条件
下で短時間に形成し得るので、不安定な生物学的
物質や機能性物質およびカプセル体の使用目的に
応じその他の種々の添加物を、カプセル体の芯部
を構成する前記流動体に添加して分散させること
ができるので、種々の有用物質を芯液に含有させ
たカプセル体を提供することが可能となる。
As mentioned above, in the present invention, the gel film of the capsule body can be formed in a short period of time under extremely mild conditions, that is, biologically mild conditions, without using organic solvents. Biological substances, functional substances, and other various additives depending on the purpose of use of the capsule can be added and dispersed in the fluid that constitutes the core of the capsule, so that various useful substances can be added. It becomes possible to provide a capsule body containing in the core liquid.

このように芯液に含有させるものとしては、動
物細胞や植物細胞を培養液に分散させたものを例
示することができる。このような生物学的物質や
あるいは機能性物質を芯液に含有させると、その
活性の低下を防止することができる。
Examples of things that can be included in the core liquid include animal cells and plant cells dispersed in a culture solution. When such biological substances or functional substances are contained in the core liquid, a decrease in the activity can be prevented.

又、本発明は、ゲル皮膜の形成によるカプセル
化を1段階で行ない得るので、例えば特開昭57−
197031号にみられるポリアニオンとポリカチオン
間の塩架橋を利用した公知のカプセル化法に比し
製造上有利であるといえる。
In addition, the present invention enables encapsulation by forming a gel film in one step.
It can be said that this method is advantageous in terms of production compared to the known encapsulation method that utilizes salt crosslinking between a polyanion and a polycation as seen in No. 197031.

更に、本発明ではカプセル体のゲル皮膜の形成
条件をコントロールすることにより、該皮膜の膜
透過性を変化させることも可能であるので、カプ
セル体の皮膜に分画機能を付与することも可能と
なる。
Furthermore, in the present invention, by controlling the formation conditions of the gel film of the capsule body, it is possible to change the membrane permeability of the gel film, so it is also possible to impart a fractionation function to the film of the capsule body. Become.

叙上のとおり、本発明によると、入手の容易な
原材料を用いて簡易な製造手段でしかも短時間
で、広範囲な用途に供し得るカプセル体を提供し
得る利点がある。
As described above, the present invention has the advantage of being able to provide a capsule body that can be used in a wide range of applications by using easily available raw materials, by simple manufacturing means, and in a short period of time.

発明の実施例及び効果 以下に実施例を示して本発明を更に具体的に説
明する。
EXAMPLES AND EFFECTS OF THE INVENTION The present invention will be explained in more detail with reference to Examples below.

実施例 1 0.1モル/酢酸と0.1モル/酢酸ナトリウム
を含む水溶液にキトサンを添加して、0.7重量%
キトサン水溶液を調製した。このキトサン水溶液
中に、25℃の温度で攪拌しながら別に調製してお
いたトリポリリン酸ナトリウムの1重量%水溶液
を内径0.4mmの注射針を介して加圧滴下させた。
Example 1 Chitosan was added to an aqueous solution containing 0.1 mol/acetic acid and 0.1 mol/sodium acetate to give a concentration of 0.7% by weight.
A chitosan aqueous solution was prepared. A separately prepared 1% by weight aqueous solution of sodium tripolyphosphate was dripped under pressure into this chitosan aqueous solution with stirring at a temperature of 25° C. through a syringe needle with an inner diameter of 0.4 mm.

この滴下による上記両液の接触後2〜3分間で
直径2〜3mmの球形カプセルが形成した。得られ
たカプセル体の皮膜は白色であつて、このカプセ
ル体を長時間水中に放置してもそれに内包されて
いる芯液は安定な流動性を示し何ら変化はみられ
なかつた。
A spherical capsule with a diameter of 2 to 3 mm was formed within 2 to 3 minutes after the two solutions came into contact with each other by this dropping. The membrane of the obtained capsule body was white, and even when the capsule body was left in water for a long time, the core liquid contained therein showed stable fluidity and no change was observed.

実施例 2 実施例1と同様にして調製したキトサン水溶液
中に25℃の温度で、別に調製しておいた1重量%
のメタリン酸ナトリウムの水溶液を実施例1と同
様にして滴下して直径2〜3mmの球形カプセルを
形成した。
Example 2 A separately prepared 1% by weight was added to a chitosan aqueous solution prepared in the same manner as in Example 1 at a temperature of 25°C.
An aqueous solution of sodium metaphosphate was added dropwise in the same manner as in Example 1 to form spherical capsules with a diameter of 2 to 3 mm.

得られたカプセル体の膜は白色であり、強度も
かなり高いことが認められた。又、カプセル体を
水中に長時間放置しても、それに内包されている
芯部は安定な流動性を保持した。
The membrane of the obtained capsule body was white and was found to have considerably high strength. Furthermore, even if the capsule body was left in water for a long time, the core contained therein maintained stable fluidity.

Claims (1)

【特許請求の範囲】 1 ポリリン酸、メタリン酸、ピロリン酸または
それらの塩の単独もしくはそれらの混合物を基材
とする流動体と、可溶性キチン誘導体の溶液との
接触により形成されたゲル皮膜で、上記流動体を
芯部として内包せしめてなるカプセル体。 2 ポリリン酸、メタリン酸、ピロリン酸または
それらの塩の単独もしくはそれらの混合物を含む
水溶液から成るカプセル体の芯部を構成する流動
体を、可溶性キチン誘導体の溶液に滴下して生物
学的に温和な条件下で接触させてゲル皮膜を形成
させ、上記流動体を芯部として内包せしめてなる
カプセル体の製造法。
[Scope of Claims] 1. A gel film formed by contacting a fluid based on polyphosphoric acid, metaphosphoric acid, pyrophosphoric acid or a salt thereof or a mixture thereof with a solution of a soluble chitin derivative, A capsule body containing the above-mentioned fluid as a core. 2. Drop the fluid constituting the core of the capsule body, which is an aqueous solution containing polyphosphoric acid, metaphosphoric acid, pyrophosphoric acid, or a salt thereof or a mixture thereof, into a solution of a soluble chitin derivative to make it biologically mild. A method for producing a capsule body, which comprises contacting the fluid under suitable conditions to form a gel film, and encapsulating the fluid as a core.
JP59272783A 1984-12-26 1984-12-26 Novel capsule body and its production Granted JPS61153135A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP59272783A JPS61153135A (en) 1984-12-26 1984-12-26 Novel capsule body and its production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59272783A JPS61153135A (en) 1984-12-26 1984-12-26 Novel capsule body and its production

Publications (2)

Publication Number Publication Date
JPS61153135A JPS61153135A (en) 1986-07-11
JPH058049B2 true JPH058049B2 (en) 1993-02-01

Family

ID=17518685

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59272783A Granted JPS61153135A (en) 1984-12-26 1984-12-26 Novel capsule body and its production

Country Status (1)

Country Link
JP (1) JPS61153135A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2797005B2 (en) * 1989-10-16 1998-09-17 雪印乳業株式会社 Cotton-like gelling substance, pulp-like jelly using the same as raw material, and method for producing the same
EP1243319A1 (en) * 2001-03-22 2002-09-25 Primacare S.L., c/o Cognis Iberica S.L. Microcapsules (XI)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6078634A (en) * 1983-10-04 1985-05-04 Ichimaru Fuarukosu Kk Enmicrocapsulation method using chitosan as film forming substance

Also Published As

Publication number Publication date
JPS61153135A (en) 1986-07-11

Similar Documents

Publication Publication Date Title
US5089272A (en) Process for producing capsules having a permeability-controllable membrane
Wang et al. Preparation, characterization and applications of low-molecular-weight alginate–oligochitosan nanocapsules
DE3432143C2 (en) Process for encapsulating a material to be encapsulated and capsules thus produced
CN106467613A (en) A kind of self-healing polyanion-chitin quarternary ammonium salt aquagel and its application
CN108676177A (en) It is a kind of using nano-starch particle as the intelligent aqueous gel processing method of skeleton
WO1989001034A1 (en) Encapsulation of biological materials in semi-permeable membranes
US4927761A (en) Immobilization of cells with alginate and agarose
DE1939347A1 (en) Enzymatically active substances
JPH0453583B2 (en)
DE3315201C2 (en)
JPH058049B2 (en)
EP0017176B1 (en) Process for immobilizing enzymatically active preparations
ATE34407T1 (en) ENCAPSULATED CELLS, PROCESS FOR THEIR PRODUCTION AND THEIR USE.
CH660199A5 (en) Method for producing microorganisms immobilized.
JP4665131B2 (en) POLYMER ELECTROLYTE COMPOSITE AND METHOD FOR PRODUCING THE SAME
RU2709181C1 (en) Method of producing gels for medical purposes based on l-cysteine, silver nitrate and polyvinyl alcohol
JPS6363388A (en) Production of low molecular weight chitosan
RU2657608C1 (en) Method for obtaining polysaccharide-containing polymer matrices
EP0246469B1 (en) Process for encapsulating biologically active material
JPS6111139A (en) Capsule body encapsulating instable functional substance and its manufacture
RU2220716C1 (en) Method for preparing microcapsule containing live microorganisms
JPH01245848A (en) Production of capsule body with film of controllable permeability
KR20010025930A (en) Preparation methods of chitosan polyelectrolyte complex microcapsule
DE69120319T2 (en) Enclosed immobilized biocatalysts and processes for their manufacture
RU2099352C1 (en) Method for production of hydrogel-forming agent of chitosan

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees